While that study highlighted a handful of variants associated with modest differences in outcomes, this work identifies combinatorial biomarker signatures that stratify patients and quantitatively predict responseand is already being translated into tests designed for use in real treatment decisions, a company representative told Inside Precision Medicine
*** SHOW NOTES [ 00:00 ] Introduction [ 02:17 ] Preparing for a GLP-1 journey [ 04:00 ] What "nutrient-dense" really means [ 06:08 ] Fiber, satiety, and metabolic health [ 07:18 ] Building sustainable habits [ 08:46 ] The hidden risks of skipping meals [ 12:42 ] Meal prep for real life [ 15:25 ] Naturally stimulating your body's own GLP-1 [ 17:26 ] Foods that naturally increase GLP-1 [ 19:16 ] Supplements that may help [ 22:43 ] The new GLP-1 pill formulations [ 28:00 ] Personalized medicine and the future of obesity treatment [ 29:24 ] Hunger isn't the enemy [ 31:10 ] Transitioning off GLP-1 medications [ 40:09 ] The mindset component [ 43:08 ] Managing food noise after GLP-1s [ 45:46 ] Exercise and long-term weight maintenance [ 48:38 ] The future of GLP-1s\ [ 50:03 ] Melissa's work and resources *** Get Connected with Elizabeth McGann: Coaching Website: Instagram: Facebook: LinkedIn: X/Twitter: *** Learn more about Melissa Mitri Instagram: @the.weightloss.dietitian Website: 53m - Jun 3, 2026 GLP-1s and the Freedom Nobody's Talking About In this solo episode, Elizabeth explores what most people are missing about GLP-1s
This is not standard practice but is worth discussing with a healthcare provider if tolerability is a problem
You can do this a number of ways
Through a telehealth model: a licensed provider reviews an intake and, if appropriate, issues a prescription routed to a retail pharmacy for branded semaglutide or a 503A compounding pharmacy for compounded semaglutide
